BG105009A - Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline - Google Patents

Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline

Info

Publication number
BG105009A
BG105009A BG105009A BG10500900A BG105009A BG 105009 A BG105009 A BG 105009A BG 105009 A BG105009 A BG 105009A BG 10500900 A BG10500900 A BG 10500900A BG 105009 A BG105009 A BG 105009A
Authority
BG
Bulgaria
Prior art keywords
carboxyamino
tetrahydroquinoline
substituted
producing
preparation
Prior art date
Application number
BG105009A
Other languages
Bulgarian (bg)
English (en)
Inventor
David DAMON
Robert DUGGER
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG105009A publication Critical patent/BG105009A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG105009A 1999-11-30 2000-11-30 Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline BG105009A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16796799P 1999-11-30 1999-11-30

Publications (1)

Publication Number Publication Date
BG105009A true BG105009A (en) 2001-11-30

Family

ID=22609556

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105009A BG105009A (en) 1999-11-30 2000-11-30 Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline

Country Status (44)

Country Link
US (1) US6313142B1 (OSRAM)
EP (1) EP1125929B1 (OSRAM)
JP (1) JP3579345B2 (OSRAM)
KR (1) KR100408177B1 (OSRAM)
CN (1) CN1173953C (OSRAM)
AP (1) AP2000002011A0 (OSRAM)
AR (1) AR029775A1 (OSRAM)
AT (1) ATE315028T1 (OSRAM)
AU (1) AU784694B2 (OSRAM)
BG (1) BG105009A (OSRAM)
BR (1) BR0005636A (OSRAM)
CA (1) CA2327029C (OSRAM)
CO (1) CO5261552A1 (OSRAM)
CY (1) CY1104989T1 (OSRAM)
CZ (1) CZ20004407A3 (OSRAM)
DE (1) DE60025317T2 (OSRAM)
DK (1) DK1125929T3 (OSRAM)
DZ (1) DZ3079A1 (OSRAM)
EA (1) EA003668B1 (OSRAM)
EE (1) EE200000659A (OSRAM)
ES (1) ES2254109T3 (OSRAM)
GE (1) GEP20022798B (OSRAM)
GT (1) GT200000190A (OSRAM)
HN (1) HN2000000203A (OSRAM)
HR (1) HRP20000804A2 (OSRAM)
HU (1) HUP0004747A3 (OSRAM)
ID (1) ID28489A (OSRAM)
IL (1) IL139849A (OSRAM)
IS (1) IS5715A (OSRAM)
MA (1) MA25223A1 (OSRAM)
NO (1) NO20006039L (OSRAM)
NZ (1) NZ508509A (OSRAM)
OA (1) OA11494A (OSRAM)
PA (1) PA8503801A1 (OSRAM)
PE (1) PE20010913A1 (OSRAM)
PL (1) PL344208A1 (OSRAM)
SG (1) SG102603A1 (OSRAM)
SK (1) SK17792000A3 (OSRAM)
TN (1) TNSN00230A1 (OSRAM)
TW (1) TW591016B (OSRAM)
UA (1) UA65615C2 (OSRAM)
UY (1) UY26451A1 (OSRAM)
YU (1) YU71500A (OSRAM)
ZA (1) ZA200006947B (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
CA2470931A1 (en) * 2001-12-19 2003-07-03 Atherogenics, Inc. Chalcone derivatives and their use to treat diseases
AU2002361811A1 (en) 2001-12-19 2003-07-09 Atherogenics, Inc. 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
CA2480439C (en) * 2002-04-11 2012-08-21 Roar Holding Llc Ex vivo method for determination of cetp activity and efficacy of heart disease treatment
KR20050055747A (ko) * 2002-10-04 2005-06-13 밀레니엄 파머슈티컬스 인코퍼레이티드 염증 질환 치료용의 ｐｇｄ2 수용체 길항제
US20090181966A1 (en) * 2002-10-04 2009-07-16 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7504508B2 (en) * 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7223870B2 (en) * 2002-11-01 2007-05-29 Pfizer Inc. Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
AU2003303239A1 (en) * 2002-12-19 2004-07-14 Atherogenics, Inc. Process of making chalcone derivatives
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
MXPA05005813A (es) 2002-12-20 2005-12-12 Pfizer Prod Inc Formas de dosificacion que comprenden un inhibidor de la cetp y un inhibidor de la hmg-coa reductasa.
WO2004078730A2 (en) * 2003-03-04 2004-09-16 Takasago International Corporation Method for producing optically active amines
EP1603554A1 (en) * 2003-03-17 2005-12-14 Japan Tobacco Inc. Method for increasing the oral bioavailability of s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate
SI1603553T1 (sl) * 2003-03-17 2012-03-30 Japan Tobacco Inc Farmacevtski sestavki CETP inhibitorjev
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
CA2537942A1 (en) * 2003-10-08 2005-04-28 Eli Lilly And Company Compounds and methods for treating dyslipidemia
UA90269C2 (ru) * 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Тетрагидрохинолиновые производные и способ их получения
US20080269284A1 (en) * 2004-06-24 2008-10-30 Eli Lilly And Company Compounds and Methods for Treating Dyslipidemia
DOP2005000123A (es) * 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
WO2006033001A1 (en) * 2004-09-23 2006-03-30 Pfizer Products Inc. Quinoline compounds
US7700774B2 (en) * 2004-12-20 2010-04-20 Dr. Reddy's Laboratories Ltd. Heterocyclic compounds and their pharmaceutical compositions
RU2007135224A (ru) * 2005-02-24 2009-03-27 Милленниум Фармасьютикалз, Инк. (Us) Антагонисты рецептора pgd2 для лечения воспалительных заболеваний
UY30244A1 (es) 2006-03-30 2007-11-30 Tanabe Seiyaku Co Un proceso para preparar derivados de tetrahidroquinolina
TW200901959A (en) 2007-03-09 2009-01-16 Indigene Pharmaceuticals Inc Combination of metformin R-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
CN101429160B (zh) * 2007-11-06 2011-10-19 上海药明康德新药开发有限公司 一种1-r-4-氨基-1,2,3,4-四氢喹啉的合成方法
AR077208A1 (es) * 2009-06-30 2011-08-10 Lilly Co Eli Derivados del acido trans-4-[[(5s)-5-[[[3,5-bis(trifluorometil) fenil] metil] (2-metil-2h-tetrazol-5-il) amino) -2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il) metil)-ciclohexancarboxilico y sus formas cristalinas, composiciones farmaceuticas que los comprenden, su uso para preparar un medicam
KR20250049276A (ko) 2022-07-05 2025-04-11 뉴암스테르담 파마 비.브이. 오비세트라피브(obicetrapib)의 염 및 그의 제조 방법 및 그의 중간체

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7870M (OSRAM) * 1968-11-08 1970-04-27
US3971789A (en) 1972-10-21 1976-07-27 John Wyeth & Brother Limited O-(4-Quinolylamino)benzamides
GB8432091D0 (en) 1984-12-19 1985-01-30 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
US4839368A (en) 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
GB8804444D0 (en) 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5231102A (en) 1989-03-08 1993-07-27 Merck Sharp & Dohme, Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6140342A (en) 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6147089A (en) 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.

Also Published As

Publication number Publication date
UA65615C2 (uk) 2004-04-15
DK1125929T3 (da) 2006-04-03
AP2000002011A0 (en) 2000-12-31
KR100408177B1 (ko) 2003-12-01
IS5715A (is) 2001-05-31
HN2000000203A (es) 2001-06-13
DZ3079A1 (fr) 2004-10-24
UY26451A1 (es) 2001-06-29
GEP20022798B (en) 2002-09-25
EA003668B1 (ru) 2003-08-28
YU71500A (sh) 2003-02-28
DE60025317T2 (de) 2006-08-03
AR029775A1 (es) 2003-07-16
AU784694B2 (en) 2006-06-01
EP1125929A1 (en) 2001-08-22
NO20006039L (no) 2001-05-31
US6313142B1 (en) 2001-11-06
ID28489A (id) 2001-05-31
HU0004747D0 (OSRAM) 2001-02-28
JP2001163859A (ja) 2001-06-19
DE60025317D1 (de) 2006-03-30
JP3579345B2 (ja) 2004-10-20
OA11494A (en) 2004-05-07
GT200000190A (es) 2002-04-27
SG102603A1 (en) 2004-03-26
CN1173953C (zh) 2004-11-03
ZA200006947B (en) 2002-05-27
CA2327029C (en) 2005-08-09
BR0005636A (pt) 2001-07-17
PL344208A1 (en) 2001-06-04
PE20010913A1 (es) 2001-09-10
ES2254109T3 (es) 2006-06-16
CZ20004407A3 (cs) 2002-06-12
NZ508509A (en) 2001-06-29
NO20006039D0 (no) 2000-11-29
HRP20000804A2 (en) 2001-06-30
CY1104989T1 (el) 2010-03-03
EA200001129A2 (ru) 2001-06-25
ATE315028T1 (de) 2006-02-15
TW591016B (en) 2004-06-11
CO5261552A1 (es) 2003-03-31
IL139849A (en) 2006-10-31
IL139849A0 (en) 2002-02-10
SK17792000A3 (sk) 2002-10-08
CN1302800A (zh) 2001-07-11
EE200000659A (et) 2001-08-15
PA8503801A1 (es) 2002-07-30
HUP0004747A2 (hu) 2001-10-28
EA200001129A3 (ru) 2001-10-22
HUP0004747A3 (en) 2002-12-28
CA2327029A1 (en) 2001-05-30
AU7178900A (en) 2001-05-31
MA25223A1 (fr) 2001-07-02
KR20010052012A (ko) 2001-06-25
TNSN00230A1 (fr) 2005-11-10
EP1125929B1 (en) 2006-01-04
HK1038007A1 (en) 2002-03-01

Similar Documents

Publication Publication Date Title
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
IL140419A0 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
AU5439899A (en) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors
AP2001002101A0 (en) 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
PL346830A1 (en) 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
AU4913800A (en) Method for condensing polyamides
YU61103A (sh) Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
WO2003037863A3 (de) Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
MY120237A (en) Method for the synthesis of quinoline derivatives
BG103649A (en) Method for the preparation of eprosartan
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
BG106002A (en) Process for preparing pesticidal intermediates
IN187760B (OSRAM)
BG103650A (en) Method for the preparation of eprosartan
MX225445B (es) Metodo y produccion de n-fosfonometilglicina.
MXPA02003042A (es) Proceso para prevenir formacion de incrustaciones.
IL152295A0 (en) Method for producing 2-alkyl-3-chlorophenols
IL133923A0 (en) Method for preparing 3-cyano-2,4-dihalogen-5-fluoro-benzoic acid
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
YU62800A (sh) Postupak za proizvodnju r-(+)-6- karboksamido-3n-metilamino- 1,2,3,4-tetrahidrokarbazola
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
AU6584601A (en) Method for producing indols